About

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. We also pioneer in R&D projects centered on integrating biomarker targets in all phases of drug development, from preclinical to post-marketing. Plexision’s technology can be adapted to

• Assess disease risk for several immunological disorders.
• Predict the success of a drug for a specific patient.
• Develop dosing recommendations for new immunological drugs.

Our state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.

---

Contact

• +1 (855) 753-9474
• info@plexision.com
• 4424 Penn Ave., #202, Pittsburgh, PA 15224 USA